Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 45 | 2024 | 1661 | 3.810 |
Why?
|
| Radiotherapy, Intensity-Modulated | 15 | 2019 | 801 | 2.150 |
Why?
|
| Radiotherapy Dosage | 48 | 2024 | 2898 | 1.900 |
Why?
|
| Radiometry | 15 | 2024 | 813 | 1.660 |
Why?
|
| Protons | 13 | 2023 | 1116 | 1.380 |
Why?
|
| Radiotherapy, Conformal | 13 | 2015 | 548 | 1.240 |
Why?
|
| Monte Carlo Method | 11 | 2024 | 1258 | 0.980 |
Why?
|
| Radiation Dosage | 9 | 2018 | 1958 | 0.970 |
Why?
|
| Radiosurgery | 28 | 2013 | 1342 | 0.860 |
Why?
|
| Radiotherapy, High-Energy | 5 | 2007 | 228 | 0.830 |
Why?
|
| Oropharyngeal Neoplasms | 5 | 2019 | 491 | 0.690 |
Why?
|
| Uncertainty | 6 | 2019 | 754 | 0.680 |
Why?
|
| Phantoms, Imaging | 7 | 2024 | 2526 | 0.660 |
Why?
|
| Organs at Risk | 9 | 2024 | 359 | 0.580 |
Why?
|
| Algorithms | 22 | 2022 | 14031 | 0.520 |
Why?
|
| Scattering, Radiation | 9 | 2017 | 490 | 0.520 |
Why?
|
| Linear Energy Transfer | 4 | 2024 | 152 | 0.480 |
Why?
|
| Equipment Failure Analysis | 4 | 2010 | 847 | 0.400 |
Why?
|
| Respiration | 3 | 2007 | 1657 | 0.390 |
Why?
|
| Radiotherapy | 7 | 2007 | 1499 | 0.380 |
Why?
|
| Radiation Injuries | 10 | 2018 | 1189 | 0.370 |
Why?
|
| Liposarcoma, Myxoid | 1 | 2010 | 60 | 0.340 |
Why?
|
| Movement | 5 | 2015 | 1478 | 0.330 |
Why?
|
| Quality Assurance, Health Care | 3 | 2018 | 2169 | 0.310 |
Why?
|
| Normal Distribution | 4 | 2019 | 272 | 0.300 |
Why?
|
| Equipment Design | 11 | 2018 | 3510 | 0.300 |
Why?
|
| Models, Theoretical | 5 | 2012 | 3575 | 0.300 |
Why?
|
| Infratentorial Neoplasms | 3 | 2018 | 98 | 0.300 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2010 | 333 | 0.270 |
Why?
|
| Brain Stem | 5 | 2024 | 858 | 0.270 |
Why?
|
| Immobilization | 2 | 2005 | 229 | 0.270 |
Why?
|
| Brain Neoplasms | 23 | 2024 | 9031 | 0.260 |
Why?
|
| Prostatic Neoplasms | 12 | 2019 | 11118 | 0.260 |
Why?
|
| Photons | 8 | 2018 | 589 | 0.260 |
Why?
|
| Ependymoma | 3 | 2024 | 320 | 0.250 |
Why?
|
| Brachytherapy | 8 | 2003 | 1223 | 0.250 |
Why?
|
| Chordoma | 2 | 2023 | 347 | 0.250 |
Why?
|
| Cyclotrons | 1 | 2004 | 30 | 0.240 |
Why?
|
| Relative Biological Effectiveness | 8 | 2018 | 312 | 0.240 |
Why?
|
| Stereotaxic Techniques | 8 | 2005 | 555 | 0.230 |
Why?
|
| Technology, Radiologic | 3 | 2015 | 160 | 0.220 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2005 | 290 | 0.210 |
Why?
|
| Calibration | 4 | 2022 | 818 | 0.200 |
Why?
|
| Biophysical Phenomena | 3 | 2015 | 320 | 0.200 |
Why?
|
| Medulloblastoma | 4 | 2017 | 678 | 0.190 |
Why?
|
| Sarcoma | 3 | 2015 | 1801 | 0.190 |
Why?
|
| Models, Statistical | 7 | 2019 | 5079 | 0.180 |
Why?
|
| Neuroma, Acoustic | 5 | 2005 | 459 | 0.170 |
Why?
|
| Radiotherapy, Computer-Assisted | 3 | 2000 | 90 | 0.170 |
Why?
|
| Astrocytoma | 4 | 2005 | 775 | 0.160 |
Why?
|
| Skull Base Neoplasms | 1 | 2023 | 270 | 0.160 |
Why?
|
| Particle Accelerators | 6 | 2007 | 174 | 0.160 |
Why?
|
| Reproducibility of Results | 9 | 2012 | 20098 | 0.160 |
Why?
|
| Neoplasms | 8 | 2015 | 22170 | 0.150 |
Why?
|
| Microtechnology | 1 | 2017 | 70 | 0.140 |
Why?
|
| Computer-Aided Design | 2 | 2009 | 300 | 0.140 |
Why?
|
| Mastectomy | 3 | 2015 | 1822 | 0.140 |
Why?
|
| Models, Biological | 4 | 2010 | 9469 | 0.140 |
Why?
|
| Humans | 91 | 2024 | 761504 | 0.140 |
Why?
|
| Cerebellar Neoplasms | 2 | 2017 | 586 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2020 | 20570 | 0.130 |
Why?
|
| Carotid Stenosis | 1 | 2023 | 860 | 0.130 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2015 | 882 | 0.120 |
Why?
|
| Skull | 3 | 2023 | 818 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2005 | 4063 | 0.120 |
Why?
|
| Thoracic Wall | 2 | 2013 | 202 | 0.120 |
Why?
|
| Computer Simulation | 8 | 2010 | 6240 | 0.120 |
Why?
|
| Lung Neoplasms | 3 | 2013 | 13380 | 0.110 |
Why?
|
| Probability | 1 | 2019 | 2477 | 0.110 |
Why?
|
| User-Computer Interface | 1 | 2000 | 1400 | 0.110 |
Why?
|
| Radiodermatitis | 1 | 2013 | 60 | 0.110 |
Why?
|
| Models, Structural | 2 | 1993 | 340 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2019 | 36426 | 0.100 |
Why?
|
| Sensitivity and Specificity | 5 | 2009 | 14666 | 0.100 |
Why?
|
| Quality Control | 2 | 2006 | 832 | 0.100 |
Why?
|
| Ions | 1 | 2012 | 256 | 0.090 |
Why?
|
| Radiation, Ionizing | 1 | 2012 | 251 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 2 | 2023 | 2895 | 0.090 |
Why?
|
| Breast Neoplasms | 7 | 2015 | 21012 | 0.090 |
Why?
|
| Leg | 1 | 2015 | 1088 | 0.090 |
Why?
|
| Spine | 1 | 2017 | 1118 | 0.090 |
Why?
|
| Biophysics | 2 | 2005 | 380 | 0.080 |
Why?
|
| Patient Care Planning | 1 | 2015 | 908 | 0.080 |
Why?
|
| Software | 4 | 2012 | 4434 | 0.080 |
Why?
|
| Carcinoma | 3 | 2015 | 2330 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1994 | 1068 | 0.080 |
Why?
|
| Cobalt Radioisotopes | 1 | 1988 | 75 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2015 | 1468 | 0.080 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2015 | 1159 | 0.070 |
Why?
|
| Mammaplasty | 2 | 2013 | 1239 | 0.070 |
Why?
|
| Mathematics | 3 | 1992 | 707 | 0.060 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 2915 | 0.060 |
Why?
|
| Rectum | 4 | 2003 | 892 | 0.060 |
Why?
|
| Male | 33 | 2019 | 360804 | 0.060 |
Why?
|
| Radiography | 6 | 2013 | 6965 | 0.060 |
Why?
|
| Cavernous Sinus | 2 | 1997 | 123 | 0.060 |
Why?
|
| Time Factors | 7 | 2015 | 39967 | 0.060 |
Why?
|
| Restraint, Physical | 1 | 2005 | 187 | 0.060 |
Why?
|
| Retinoblastoma | 2 | 1998 | 317 | 0.060 |
Why?
|
| Respiratory System | 1 | 2007 | 563 | 0.060 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2008 | 857 | 0.060 |
Why?
|
| Urethra | 2 | 2003 | 405 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 2011 | 1250 | 0.050 |
Why?
|
| Silicon | 1 | 2024 | 142 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2265 | 0.050 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2015 | 916 | 0.050 |
Why?
|
| Motion | 1 | 2005 | 779 | 0.050 |
Why?
|
| Urinary Bladder | 3 | 2003 | 1152 | 0.050 |
Why?
|
| Radiation Oncology | 1 | 2008 | 563 | 0.050 |
Why?
|
| Child | 18 | 2023 | 80153 | 0.050 |
Why?
|
| Computer Systems | 3 | 2003 | 470 | 0.050 |
Why?
|
| Posture | 1 | 2005 | 957 | 0.050 |
Why?
|
| Germinoma | 1 | 2001 | 132 | 0.050 |
Why?
|
| Feasibility Studies | 4 | 2017 | 5247 | 0.050 |
Why?
|
| Iodine Radioisotopes | 3 | 2000 | 1031 | 0.040 |
Why?
|
| Stroke | 1 | 2023 | 9757 | 0.040 |
Why?
|
| Reference Standards | 1 | 2003 | 1003 | 0.040 |
Why?
|
| Adolescent | 16 | 2017 | 88319 | 0.040 |
Why?
|
| Optic Nerve Neoplasms | 1 | 1999 | 45 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 1992 | 3530 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4320 | 0.040 |
Why?
|
| Meningeal Neoplasms | 2 | 1997 | 1248 | 0.040 |
Why?
|
| Necrosis | 2 | 2018 | 1611 | 0.040 |
Why?
|
| Image Enhancement | 2 | 2000 | 2885 | 0.030 |
Why?
|
| Texas | 1 | 2018 | 404 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 2017 | 2927 | 0.030 |
Why?
|
| Florida | 1 | 2018 | 431 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2018 | 297 | 0.030 |
Why?
|
| Glioma | 4 | 1999 | 3455 | 0.030 |
Why?
|
| Child, Preschool | 11 | 2017 | 42230 | 0.030 |
Why?
|
| Eye Neoplasms | 1 | 1998 | 307 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 2 | 2003 | 2469 | 0.030 |
Why?
|
| Retrospective Studies | 10 | 2019 | 80636 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2003 | 1116 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2015 | 1784 | 0.030 |
Why?
|
| Germany | 1 | 2018 | 875 | 0.030 |
Why?
|
| Rhabdoid Tumor | 1 | 2017 | 210 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2000 | 9000 | 0.030 |
Why?
|
| Follow-Up Studies | 11 | 2017 | 39106 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2003 | 1824 | 0.030 |
Why?
|
| Growth Plate | 1 | 2017 | 274 | 0.030 |
Why?
|
| Glioblastoma | 4 | 2001 | 3482 | 0.030 |
Why?
|
| Cancer Care Facilities | 1 | 2018 | 422 | 0.030 |
Why?
|
| Treatment Outcome | 10 | 2015 | 64680 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 5315 | 0.030 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1997 | 266 | 0.030 |
Why?
|
| Teratoma | 1 | 2017 | 404 | 0.030 |
Why?
|
| Middle Aged | 22 | 2013 | 220895 | 0.030 |
Why?
|
| Glomus Jugulare Tumor | 1 | 1994 | 35 | 0.030 |
Why?
|
| Abducens Nerve | 1 | 1993 | 28 | 0.030 |
Why?
|
| Trochlear Nerve | 1 | 1993 | 26 | 0.030 |
Why?
|
| Adenocarcinoma | 3 | 2003 | 6346 | 0.030 |
Why?
|
| Ondansetron | 1 | 1994 | 95 | 0.030 |
Why?
|
| Pelvic Neoplasms | 1 | 2015 | 247 | 0.030 |
Why?
|
| Palatal Neoplasms | 1 | 2013 | 37 | 0.030 |
Why?
|
| Oculomotor Nerve | 1 | 1993 | 72 | 0.030 |
Why?
|
| Thoracic Neoplasms | 1 | 2015 | 267 | 0.030 |
Why?
|
| Tonsillar Neoplasms | 1 | 2013 | 50 | 0.030 |
Why?
|
| Palate, Soft | 1 | 2013 | 100 | 0.030 |
Why?
|
| Cranial Irradiation | 1 | 1996 | 390 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2002 | 1410 | 0.030 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1997 | 549 | 0.030 |
Why?
|
| Female | 24 | 2017 | 392644 | 0.030 |
Why?
|
| Lung | 2 | 2013 | 10000 | 0.030 |
Why?
|
| Radiation Pneumonitis | 1 | 2013 | 102 | 0.030 |
Why?
|
| Infant | 6 | 2017 | 36192 | 0.020 |
Why?
|
| Trigeminal Nerve | 1 | 1993 | 248 | 0.020 |
Why?
|
| Cerebral Ventricles | 1 | 1994 | 542 | 0.020 |
Why?
|
| Tongue Neoplasms | 1 | 2013 | 183 | 0.020 |
Why?
|
| Nausea | 1 | 1994 | 679 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 1993 | 479 | 0.020 |
Why?
|
| Vomiting | 1 | 1994 | 651 | 0.020 |
Why?
|
| Meningioma | 2 | 1997 | 1218 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2005 | 9280 | 0.020 |
Why?
|
| Esophagus | 1 | 2017 | 1033 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2017 | 1206 | 0.020 |
Why?
|
| Actuarial Analysis | 3 | 1999 | 372 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2017 | 1168 | 0.020 |
Why?
|
| Optic Nerve | 1 | 1993 | 572 | 0.020 |
Why?
|
| Anisotropy | 1 | 2013 | 1283 | 0.020 |
Why?
|
| Photography | 1 | 2013 | 532 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 1997 | 1052 | 0.020 |
Why?
|
| Disease-Free Survival | 3 | 2005 | 6814 | 0.020 |
Why?
|
| Benchmarking | 1 | 2015 | 1045 | 0.020 |
Why?
|
| Aged | 17 | 2013 | 169289 | 0.020 |
Why?
|
| Adult | 19 | 2013 | 221177 | 0.020 |
Why?
|
| Electrons | 1 | 1989 | 265 | 0.020 |
Why?
|
| Gamma Rays | 1 | 1988 | 318 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2011 | 1008 | 0.020 |
Why?
|
| United States | 2 | 2018 | 72334 | 0.020 |
Why?
|
| Survival Analysis | 5 | 2001 | 10090 | 0.020 |
Why?
|
| Fatigue | 1 | 2013 | 1552 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 1893 | 0.020 |
Why?
|
| Combined Modality Therapy | 3 | 2011 | 8529 | 0.020 |
Why?
|
| Cell Communication | 1 | 2012 | 1657 | 0.020 |
Why?
|
| Massachusetts | 1 | 2018 | 8830 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 1988 | 683 | 0.010 |
Why?
|
| Reoperation | 3 | 2001 | 4303 | 0.010 |
Why?
|
| Age Factors | 2 | 2017 | 18395 | 0.010 |
Why?
|
| Life Tables | 1 | 2003 | 364 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1990 | 926 | 0.010 |
Why?
|
| Incidence | 3 | 2017 | 21353 | 0.010 |
Why?
|
| Aged, 80 and over | 6 | 2013 | 58976 | 0.010 |
Why?
|
| Cell Survival | 1 | 2012 | 5791 | 0.010 |
Why?
|
| Prostate | 2 | 2002 | 1770 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 2 | 2003 | 2827 | 0.010 |
Why?
|
| Kidney | 1 | 2017 | 7048 | 0.010 |
Why?
|
| Liver | 1 | 2017 | 7529 | 0.010 |
Why?
|
| Prone Position | 1 | 2002 | 196 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7390 | 0.010 |
Why?
|
| Time | 1 | 2002 | 546 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 2003 | 767 | 0.010 |
Why?
|
| Seminal Vesicles | 1 | 1999 | 103 | 0.010 |
Why?
|
| Perineum | 1 | 2000 | 208 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2013 | 3801 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 1999 | 6228 | 0.010 |
Why?
|
| Prospective Studies | 5 | 2005 | 54425 | 0.010 |
Why?
|
| Brain | 2 | 1995 | 27112 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2001 | 491 | 0.010 |
Why?
|
| Lens, Crystalline | 1 | 1998 | 389 | 0.010 |
Why?
|
| Disease Progression | 2 | 2005 | 13506 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 23995 | 0.010 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 1997 | 100 | 0.010 |
Why?
|
| Pituitary Neoplasms | 2 | 1996 | 1324 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2005 | 15266 | 0.010 |
Why?
|
| Skull Neoplasms | 1 | 1997 | 173 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 16981 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2003 | 3595 | 0.010 |
Why?
|
| Prochlorperazine | 1 | 1994 | 16 | 0.010 |
Why?
|
| Radiation Protection | 1 | 1998 | 424 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2000 | 11121 | 0.010 |
Why?
|
| Pons | 1 | 1995 | 240 | 0.010 |
Why?
|
| Survival Rate | 2 | 1999 | 12725 | 0.010 |
Why?
|
| Craniopharyngioma | 1 | 1996 | 277 | 0.010 |
Why?
|
| Cranial Nerve Diseases | 1 | 1993 | 113 | 0.010 |
Why?
|
| Cerebral Angiography | 1 | 1998 | 1281 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 1999 | 12059 | 0.010 |
Why?
|
| Prognosis | 2 | 2005 | 29625 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 1995 | 476 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 59243 | 0.010 |
Why?
|
| Alopecia | 1 | 1994 | 412 | 0.010 |
Why?
|
| Artifacts | 1 | 1999 | 1911 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 12463 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1995 | 2645 | 0.000 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1995 | 1496 | 0.000 |
Why?
|
| Cerebellum | 1 | 1995 | 1501 | 0.000 |
Why?
|
| Retina | 1 | 1998 | 2659 | 0.000 |
Why?
|
| Patient Selection | 1 | 1998 | 4244 | 0.000 |
Why?
|
| Adenoma | 1 | 1996 | 2160 | 0.000 |
Why?
|
| Boston | 1 | 1998 | 9326 | 0.000 |
Why?
|
| Remission Induction | 1 | 1990 | 2396 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1999 | 14605 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1994 | 8631 | 0.000 |
Why?
|
| Quality of Life | 1 | 1999 | 13367 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1995 | 15631 | 0.000 |
Why?
|
| Melanoma | 1 | 1990 | 5709 | 0.000 |
Why?
|
| Risk Factors | 1 | 1990 | 74206 | 0.000 |
Why?
|
Concepts
(257)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(50)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_